A new self-rating scale for detecting atypical or second-generation antipsychotic side effects

Journal of Psychopharmacology

Volumn 22, Issue 3, 2008, Pages 238-243

  Waddell, L ^a   Taylor, M ^b  

^a SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^b Springpark Centre   (United Kingdom)

Author keywords

Antipsychotic agents adverse effects; Atypical antipsychotics; Drug monitoring; Neuroleptic drugs; Questionnaires

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; NEUROLEPTIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONSTRUCT VALIDITY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; DRUG INFORMATION; DRUG MONITORING; FEMALE; GLASGOW ANTIPSYCHOTIC SIDE EFFECT SCALE; HUMAN; LIVERPOOL UNIVERSITY NEUROLEPTIC SIDE EFFECT RATING SCALE; MALE; MEDICAL ASSESSMENT; MEDICAL LITERATURE; MEDICAL SPECIALIST; MENTAL HEALTH; PRIORITY JOURNAL; RATING SCALE; SELF CONCEPT; TEST RETEST RELIABILITY;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SELF CONCEPT;

EID: 45349098513     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881107087976     Document Type: Article

References (19)

1. Barnes, TR (1989) A rating scale for drug-induced akathisia. Br J Psychiatry 154: 672-676.
2. Chouinard, G., Ross-Chouinard, A., Annable, L. (1980) Extrapyramidal Rating Scale. Can J Neurol Sci 7: 233-239.
3. Day, JC, Wood, G., Dewey, M., Bentall, RP (1995) A Self-rating scale for measuring neuroleptic side-effects. Validation in a group of schizophrenic patients. Br J Psychiatry 166: 650-653.
4. Fleischhaker, W., Bergmann, K., Perovich, R. (1989) The Hillside Akathisia Scale: a new rating instrument for neuroleptic-induced akathisia. Psychopharmacol Bull 25: 222-226.
5. Geddes, J., Freemantle, N., Harrison, P., Bebbington, P. (2000) Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. Br Med J 321: 1371-1376.
6. Guy, W. (1976) ECDEU assessment manual for psychopharmacology. Revised. Rockville, MD: U.S. Department of Health, Education, and Welfare, Alcohol, Drug Abuse and Mental Health Administration, pp. 534-537.
7. Hogan, TP, Awad, AG, Eastwood, R. (1983) A self-report predictive of drug compliance in schizophrenia: reliability and discriminative ability. Psychol Med 13: 177-183.
8. Joint Formulary Committee (2005) British National Formulary, 5 1 ed. London: British Medical Association and Royal Pharmaceutical Society of Great Britain.
9. Lambert, M., Conus, P., Eide, P., Mass, R., Karow, A., Moritz, S., Golks, D., Naber, D. (2004) Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence. Eur Psychiatry 19: 415-422.
10. Lieberman, JA, Stroup, TS, McEvoy, JP, Swartz, MS, Rosenheck, RA, Perkins, DO, Keefe, RSE, Davis, SM, Davis, CE, Lebowitz, BD, Severe, J., Hsiao, JK (2005) Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 353: 1209-1223.
11. Lingjaerde, O., Ahlfors, UG, Bech, P., Dencker, SJ, Elgen, K. (1987) The UKU side effect rating scale: a new comprehensive rating scale for psychotropic drugs, and a cross sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand 76 (Suppl.). 1-100.
12. Medcalc Software (2006) Mariakerke, Belgium. http://www.medcalc.be. Accesseddate1/11/06.
13. Negi, R. (2007) A randomized controlled study to determine whether the use of LUNSERS improves clinician awareness. Abstract presented at Royal College of Psychiatrists' General & Community Faculty meeting, Newcastle.
14. NICE guidelines (2002) Schizophrenia: core interventions in the treatment and management of schizophrenia in primary and secondary care. http://www.nice.org.uk. Accessed date 15/01/07.
15. Patel, MP, David, AS (2007) Medication adherence: predictive factors and enhancement strategies. Psychiatry 6: 357-361.
16. Robinson, DG, Woerner, MG, Alvir, JM, Bilder, RM, Hinrichsen, GA, Lieberman, JA (2002) Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder. Schizophr Res 57: 209-219.
17. Simpson, GM, Angus, JW (1970) A rating scale for extrapyramidal side effects. Acta Psychiatr Scand 212: 11-19.
18. Tacchi, MJ, Scott, J. (2005) Improving medication adherence in schizophrenia and bipolar disorders. Chichester: John Wiley & Sons Ltd.
19. Yusufi, BZ, Mukherjee, S., Aitchison, K., Dunn, G., Page, E., Barnes, TRE (2005) Reliability of the Antipsychotic Non-Neurological Side-Effects Rating Scale (ANNSERS). J Psychopharmacol 19 (Suppl.). A10.